Up to date on cholesterol 7 alpha-hydroxylase (CYP7A1) in bile acid synthesis
Volume 4, Issue 2, June 2020, Pages 47-63
Share article
Endoplasmic reticulum stress and liver diseases
Volume 3, Issue 1, March 2019, Pages 55-64
Share article
The acidic pathway of bile acid synthesis: Not just an alternative pathway
Volume 3, Issue 2, June 2019, Pages 88-98
Share article
Bile acid receptors and gastrointestinal functions
Volume 3, Issue 1, March 2019, Pages 31-39
Share article
Pyrrolizidine alkaloids: An update on their metabolism and hepatotoxicity mechanism
Volume 3, Issues 3-4, December 2019, Pages 176-184
Share article
Mitochondrial damage and biogenesis in acetaminophen-induced liver injury
Volume 3, Issues 3-4, December 2019, Pages 150-156
Share article
Dysregulation of glutathione synthesis in liver disease
Volume 4, Issue 2, June 2020, Pages 64-73
Share article
Vitamins and non-alcoholic fatty liver disease: A molecular insight
Volume 5, Issue 2, June 2021, Pages 62-71
Share article
The role of gut microbiota in liver disease development and treatment
Volume 3, Issue 1, March 2019, Pages 3-18
Share article
Structural perspectives of the CYP3A family and their small molecule modulators in drug metabolism
Volume 3, Issues 3-4, December 2019, Pages 132-142
Share article
Nutrient mTORC1 signaling contributes to hepatic lipid metabolism in the pathogenesis of non-alcoholic fatty liver disease
Volume 4, Issue 1, March 2020, Pages 15-22
Share article
Inhibition of mitochondrial fatty acid oxidation in drug-induced hepatic steatosis
Volume 3, Issues 3-4, December 2019, Pages 157-169
Share article
Microbiome dysbiosis and alcoholic liver disease
Volume 3, Issues 3-4, December 2019, Pages 218-226
Share article
Intestinal barrier function and metabolic/liver diseases
Volume 4, Issue 2, June 2020, Pages 81-87
Share article
Bile acid receptors and signaling crosstalk in the liver, gut and brain
Volume 5, Issue 3, September 2021, Pages 105-118
Share article
Dietary fatty acids and bioactive fatty acid metabolites in alcoholic liver disease
Volume 3, Issues 3-4, December 2019, Pages 206-217
Share article
Functional roles of CCL5/RANTES in liver disease
Volume 4, Issue 1, March 2020, Pages 28-34
Share article
Metformin alleviates cholestasis-associated nephropathy through regulating oxidative stress and mitochondrial function
Volume 5, Issue 3, September 2021, Pages 171-180
Share article
Glypican-3: A molecular marker for the detection and treatment of hepatocellular carcinoma
Volume 4, Issue 4, December 2020, Pages 168-172
Share article
Overexpression of Galectin-1 and Galectin-3 in hepatocellular carcinoma
Volume 4, Issue 4, December 2020, Pages 173-179
Share article
Mitigation of cholestasis-associated hepatic and renal injury by edaravone treatment: Evaluation of its effects on oxidative stress and mitochondrial function
Volume 5, Issue 3, September 2021, Pages 181-193
Share article
Lysosome and proteasome dysfunction in alcohol-induced liver injury
Volume 3, Issues 3-4, December 2019, Pages 191-205
Share article
Lipid and energy metabolism in Wilson disease
Volume 4, Issue 1, March 2020, Pages 5-14
Share article
Chlorpromazine protects against acetaminophen-induced liver injury in mice by modulating autophagy and c-Jun N-terminal kinase activation
Volume 3, Issue 1, March 2019, Pages 65-74
Share article
Clinical perspectives of isoniazid-induced liver injury
Volume 5, Issue 2, June 2021, Pages 45-52
Share article
